
Docetrust 120 Injection
Marketer
Panacea Biotec Pharma Ltd
Salt Composition
Docetaxel (120mg)
Overview Docetrust 120 Injection
Oncaspar 120 Injection, an antineoplastic agent, treats breast, non-small cell lung, prostate, and head and neck cancers. Administered intravenously by a healthcare professional, the dosage and frequency are determined by your physician based on your condition and may vary. Strictly adhere to your doctor's instructions; incorrect usage or overdose can cause severe adverse reactions. Therapeutic effects may take weeks or months to manifest; discontinue only under medical supervision. Common side effects include dyspnea, constipation, edema, infections, anorexia, myalgia, onychopathy, pain, and asthenia. Your doctor might prescribe additional medication to mitigate these. Report immediate unexplained bleeding or bruising, pharyngitis, oral ulcers, or pyrexia. This medication can reduce blood cell counts (leukopenia and anemia), increasing infection risk. Regular blood tests to monitor blood cell levels and liver function are essential. Prior to treatment, disclose any heart, liver, or kidney conditions, and all other medications, including antibiotics, as drug interactions are possible. This injection is contraindicated during pregnancy and lactation; reliable contraception for both partners is crucial throughout treatment.
Uses of Docetrust 120 Injection
Cancers of the breast, lung (non-small cell), prostate, and head and neck.
Major Benefits of Docetrust 120 Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Docetrust 120 Injection:
- Breathlessness
- Constipation
- Edema (swelling)
- Infection
- Loss of appetite
- Muscle pain
- Nail disorder
- Pain
- Weakness
How to use Docetrust 120 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Docetrust 120 Injection works:
Oncotrust 120 Injection is a chemotherapy agent. Its mechanism of action involves disruption of microtubule networks, essential for cancer cell proliferation. This inhibits cancerous cell growth, ultimately leading to their demise.
SAFETY ADVICE
AlcoholUNSAFE
Combining Docetrust 120 Injection and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Administering Docetrust 120 Injection during pregnancy is contraindicated due to confirmed fetal risks. Exceptions may exist in dire circumstances where the potential benefits outweigh the hazards, at the physician's sole discretion. Physician consultation is essential.
Breast feedingUNSAFE
Administering Docetrust 120 Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingCONSULT YOUR DOCTOR
The effect of Docetrust 120 Injection on driving ability is unknown. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For patients with kidney impairment, Docetrust 120 Injection poses no safety concerns. No dosage modification is advised for this medication.
LiverCAUTION
Individuals with hepatic impairment should use Docetrust 120 Injection cautiously. Dosage modification of Docetrust 120 Injection might be necessary. Physician consultation is advised.
What if you forget to take Docetrust 120 Injection :
NA
Facts to Know About Docetrust 120 Injection
| Label | Value |
|---|---|
| Chemical Type | Taxane-Based Compounds |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Taxanes: Antimicrotubule Agents |
